glp-1 drug boom The that shook global pharma is now India’s #1 selling medicine — and the biggest money isn’t where 99% are looking., Mounjaro became India’s top-selling drug by value within 7 months of launch. Novo cuts GLP-1 prices 70%,

Fiber has been shown to lower bad LDL cholesterol while raising good HDL cholesterol

[DOI] [PMC free article] [PubMed] [Google Scholar] Li H, Wang Y, Wei C, Bai S, Zhao Y, Li H, Wu B, Wang R, Wu L, Xu C

Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes

10.1186/s40168-018-0461-0 66 HucT.DrapalaA.GawrysM.KonopM.BielinskaK.ZaorskaE.et al (2018)

Si bien la protena animal es necesaria para el crecimiento, el mantenimiento y la reparacin de todas las partes del cuerpo, la dieta debe equilibrarse correctamente